|
|
CO2-H+ Chemoreceptors: Where Are They, What Do
They Do?
Sponsored by the APS Respiration Section
Mon. April 3—3:15-5:15 PM
|
| Chaired: |
Hubert V. Forster,
Med. Col. of Wisconsin
Matt Hodges, |
Elegant studies in the 50s,
60s, and 70s provided strong evidence that CO2-H+
chemoreception was restricted to sites near the ventrolateral medullary
surface. However, several recent studies suggest that CO2-H+
chemoreceptors are located at widespread sites in the brainstem, and that
the carotid bodies are a major determinant of the ventilatory response to
increased CO2-H+ in awake mammals. These findings have
posed several questions, some of which will be addressed by the speakers in
this symposium. Are all chemoreceptors capable of influencing breathing, and
do they only influence breathing? Do the physiologic responses to changes in
chemoreceptor activity differ between anesthetized, awake, and asleep
states? Is there a hierarchy among chemoreceptors in their influence on
breathing? Do chemoreceptors at all brainstem sites have the same response
characteristics? Are all brainstem chemoreceptors uniform in their
neurochemical phenotype? Why did chemosensitivity develop at widespread
brain sites? Are the carotid bodies primary CO2-H+
chemoreceptors, or does the carotid body provide a tonic input to medullary
neurons that is necessary for the normal response to central chemoreceptors?
|
3:15 PM |
The history of the role of cerebrospinal fluid pH in CO2-H+
chemoreception.
John Severinghaus, Univ. of California, San Franciso
|
|
3:30 PM |
The physiological significance of multiple central chemoreceptor
sites.
Gene Nattie, Dartmouth Med. Sch.
|
|
4:05 PM |
Retrotrapezoid nucleus and ventral surface chemoreceptor.
Patrice Guyenet, Univ. of Virginia Hlth. Sci. Ctr.
|
|
4:30 PM |
Evidence for central
chemoreceptors based on in vitro experiments.
George Richerson, Yale Univ.
|
|
4:55 PM |
The carotid bodies are a
major determinant of ventilatory CO2 sensitivity in awake
mammals.
Hubert Forster, Med. Col. of Wisconsin |
|
|